Delivery Order SPE2DB20D7061-SPE2DB25FSMQ0
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,770.94 firm fixed-price delivery order contract is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of May 31, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,557.67 firm fixed-price delivery order is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of January 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,892.61, is a delivery order for the pharmaceutical product CONTRAVE ER 8-90 MG TABLET 120S. The contract has a firm fixed price pricing type and an ultimate completion date of April 15, 2025. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,529.68 Firm Fixed Price delivery order contract is for the supply of CONTRAVE ER 8/90MG 120, a medication. The contract has an ultimate completion date of October 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,244.58 firm fixed-price delivery order contract is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a medication. The contract has an ultimate completion date of March 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,235.12 delivery order contract is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, with a period of performance through March 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,663.83 firm fixed-price delivery order is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of June 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CONTRAVE ER 8-90 MG TABLET 120S. The contract has a firm fixed price of $7,792.96 and a completion date of February 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for...
- This federal contract award, valued at $3,797.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, with a completion date of May 31, 2024. This contract appears to be a delivery order and is not associated with a set-aside designation, indicating open competition. AmerisourceBergen also holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,786.30, is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract has a period of performance through December 30, 2024 and is a firm fixed-price delivery order. This award is not set aside for any specific business type. AmerisourceBergen...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB25FSMQ0Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $18,709.96 with a firm fixed price, for the delivery of CONTRAVE ER 8-90 MG TABLET 120S. The contract has an ultimate completion date of March 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.7k | 3/21/25 |